Using SPE and HPLC-MS to Quantify and Identify Pharmaceutical Compounds in St. John\u27s University Wastewater by Stuckey, Melissa E.
College of Saint Benedict and Saint John's University 
DigitalCommons@CSB/SJU 
Honors Theses, 1963-2015 Honors Program 
2014 
Using SPE and HPLC-MS to Quantify and Identify Pharmaceutical 
Compounds in St. John's University Wastewater 
Melissa E. Stuckey 
College of Saint Benedict/Saint John's University 
Follow this and additional works at: https://digitalcommons.csbsju.edu/honors_theses 
 Part of the Chemistry Commons 
Recommended Citation 
Stuckey, Melissa E., "Using SPE and HPLC-MS to Quantify and Identify Pharmaceutical Compounds in St. 
John's University Wastewater" (2014). Honors Theses, 1963-2015. 49. 
https://digitalcommons.csbsju.edu/honors_theses/49 
This Thesis is brought to you for free and open access by DigitalCommons@CSB/SJU. It has been accepted for 
inclusion in Honors Theses, 1963-2015 by an authorized administrator of DigitalCommons@CSB/SJU. For more 






Using  SPE  and  HPLC-­MS  to  quantify  and  identify  pharmaceutical  
compounds  in  6W-RKQ¶V8QLYHUVLW\ZDVWHZDWHU  
AN  HONORS  THESIS      
  
College  of  St.  Benedict/St.  John's  University    
In  Partial  Fulfillment    
of  the  Requirements  for  All  College  Honors  
and  Distinction    
in  the  Department  of  Chemistry    
by    
  
Melissa  E.  Stuckey  
April,  2014  
     
Signature  Page  
Project  Title:  Using  SPE  and  HPLC-­MS  to  quantify  and  identify  pharmaceutical  
FRPSRXQGVLQ6W-RKQ¶V8QLYHUVLW\ZDVWHZDWHU  
Approved  by:  
Dr.  Alicia  A.  Peterson  
Assistant  Professor  of  Chemistry  
Dr.  Michael  R.  Ross  
Associate  Professor  of  Chemistry  
Dr.  Md  Fazal  
Assistant  Professor  of  Chemistry  
Dr.  Henry  Jakubowski  
Professor  of  Chemistry  
Dr.  Anthony  Cunningham  
Director,  Honors  Thesis  Program  
ABSTRACT  
_____________________________________________________________________________________  
Pharmaceuticals   in   wastewater   have   become   a   concern   of   environmental   toxicologists.   An   efficient  
method   of   discovering   the   concentrations   of   these   pharmaceuticals   in  wastewater   has   not   yet   been  
produced.   The  method  we   developed   includes   an   automated   Solid   Phase   Extraction   (SPE)   procedure  
prior  to  injecting  a  sample  of  wastewater  into  the  High  Performance  Liquid  Chromatograph  (HPLC)  and  
Mass   Spectrometer   ʹ   Electrospray   Ionization   (MS-­‐ESI).   Three   unknown   peaks  were   identified   on   the  
HPLC  ĂŶĚD^ĨƌŽŵǁĂƐƚĞǁĂƚĞƌŽďƚĂŝŶĞĚĨƌŽŵƚŚĞ^ƚ͘:ŽŚŶ͛ƐtĂƐƚĞǁĂƚĞƌdƌĞĂƚŵĞŶƚWůĂŶƚŝŶ:ƵŶĞϮϬϭϯ͘
Methods   of   analysis   including  NMR,  GC-­‐MS   and   IR   have   been   used   to   determine   the   composition   of  




Until   recently,   the   presence   of   pharmaceuticals   in   wastewater   has   not   been   a   concern   of  
environmental  toxicologists.  However,  studies  have  shown  that  concentrations  as  low  as  1  ppb  (part  per  
billion)  and  sometimes  1  ppt  (part  per  trillion)  can  have  adverse  environmental  effects.1  Pharmaceuticals  
can  easily  be  deposited   into  aquatic  environments  through  effluents  such  as  wastewater,  and  there   is  
little  known  about  their  possible  synergistic  effects.  Because  of  the  potential  for  biological  consequences  
in  various  communities,  including  CSB|SJU,  it  is  critical  to  determine  an  efficient  method  of  discovering  
the   concentrations   of   these   pharmaceuticals   in   wastewater.   Current   methods   of   evaluation   include  
manual  SPE  coupled  with  LC/MS-­‐ESI(+)  and  continuous  liquid-­‐liquid  extraction  (CLLE).2  
The  method  we  developed  includes  an  automated,  rather  than  manual,  SPE  procedure  prior  to  injecting  
a  pre-­‐concentrated  sample  of  wastewater  into  the  HPLC/MS-­‐ESI.  This  paper  describes  the  research  from  
June  2012  to  April  2014  to  determine  the   limit  of  detection  (LOD)  of  this  method  starting  with  known  
amounts  of  antidepressants  in  E-­‐ƉƵƌĞǁĂƚĞƌĂƐǁĞůůĂƐƚŚĞƌĞƐƵůƚƐŽĨƚĞƐƚŝŶŐǁĂƐƚĞǁĂƚĞƌĨƌŽŵ^ƚ͘:ŽŚŶ͛Ɛ
University,  Collegeville,  MN.  
METHODS   
Part  1:  Determining  the  LOD  
Preparation  of  the  antidepressant  solutions  
Six   antidepressant   drugs   were   dissolved   in   methanol   in   various   ways   to   be   prepared   into  
approximately  10  mM  solutions.  Paroxetine  HCl  (Paxil)  was  weighed  out  as  a  pure  substance  and  added  
to   a   100  mL   volumetric   flask.   Tablets   of   Sertraline   HCl   (Zoloft),   Quetiapine   Fumerate   (Geodon),   and  
Escitalopram   Oxalate   (Lexapro)   were   crushed   with   mortar   and   pistol,   transferred   into   a   100   mL  
volumetric   flask,   sonicated   for  15  minutes  with  a  Branson  2510  Ultrasonic  Cleaner,   and   filtered  using  
0.45um   nylon   filter   paper.   Similarly,   Aripiprazole   (Abilify)   was   crushed,   transferred   into   a   50   mL  
volumetric  flask  because  there  was  a  limited  supply  of  aripiprazole,  sonicated,  and  filtered.  Ziprasidone  
HCl  came  as  a  capsule,  and   the   insides  were   transferred   into   the  100  mL  volumetric   flask,  which  was  
sonicated   and   filtered.   Each   solution   was   placed   in   a   separate   amber   bottle   to   prevent   possible  
photodecomposition.  
Direct  Injection  HPLC  
One  hundred  ʅ>ŽĨĞĂĐŚǁĂƐƉůĂĐĞĚƐĞƉĂƌĂƚĞůǇŝŶƚŽϲƐŵĂůůĂŵďĞƌHPLC  vials,  and  1  mL  of  E-­‐pure  H2O  
was   added   to  each   vial.   Two   direct   injection  HPLC  methods  were   attempted  with   1.00  ʅ>   of   each  of  
these  six  solutions  that  did  not  show  any  peaks,   including  a  mobile  phase  of  50%  methanol/50%  pH  9  
ϭϬϬ ŵD ĞƚŚĂŶŽůĂŵŝŶĞ ďƵĨĨĞƌ ĂŶĚ ϵϬйŵĞƚŚĂŶŽůͬϭϬй Ɖ, ϵ ďƵĨĨĞƌ͕ ĞĂĐŚ ƌƵŶ ƚŚƌŽƵŐŚ Ă ϭϴ͕ Ϯ͘ϲʅŵ
Kinetex   analytical   column   with   the   Thermoscientific   Surveyor   HPLC   at   0.500   mL/min.   Every   HPLC  
method  used  a  wavelength  of  215  nm.  An  80%  methanol  20%  pH  9  mobile  phase  run  at  1.00  mL/min  
showed  peaks,  but  they  were  very  close  together.  At  a  flow  rate  of  0.500  mL/min,  every  peak  showed  up  
except  for  aripiprazole.  A  mobile  phase  of  70%  methanol  30%  pH  9  buffer  at  a  flow  rate  of  0.500  mL/min  
showed   consistent,   distinct   peaks   for   every   compound.   The   LC/MS   was   added   to   give   MS  
chromatograms  of  the  data  as  well.  
The  six  antidepressant  solutions  of  about  10  mM  were  then  added  together  by  placing  10  mL  of  each  
into  one  amber  bottle.  When   run  under   the  70%  methanol/30%  pH  9  buffer,  0.500  mL/min   flow   rate  
conditions,   they   showed   distinct   peaks.   When   precipitate   was   found   in   some   of   the   sample   vials  
containing  quetiapine   fumarate,  escitalopram  oxalate,  and  ziprasidone,   these  three  solutions  were  re-­‐
made  using  acetonitrile  as   the   solvent   instead  of  methanol,  but  precipitate   formed   in   the  acetonitrile  
solutions  as  well.  Equal  amounts  of  the  10  mM  solutions  of  paroxetine,  sertraline,  and  aripiprazole  were  
then  combined  in  an  amber  bottle.  The  paroxetine,  sertraline,  aripiprazole  (PSA)  solution  was  analyzed  
under   the  70%  methanol/30%  pH  9  buffer  conditions,   and   then  made  more  dilute  until   the  peaks  no  
longer  showed  in  order  to  determine  the  LOD.  This  method  was  accomplished  by  placing  500,  300,  200,  
ϭϬϬ͕ ϳϱ͕ ϱϬ͕ Ϯϱ͕ ϭϱ͕ ϭϬ͕ ĂŶĚ ϱ ʅ> into   separate   amber   vials,   adding   1  mL   of  methanol   to   each,   and  
running  it  through  the  70%  methanol/30%  pH  9  buffer  HPLC  method.  
   Manual  SPE/HPLC  
The  next  step  in  our  process  was  to  make  up  solutions  that  were  at  even  lower  concentrations  than  the  
direct   injection   HPLC  method   could   detect   and   do   a   Solid   Phase   Extraction   (SPE)   to   concentrate   the  
compound  prior  to  HPLC  injection.  Doing  this  iteratively  with  smaller  concentrations  each  time  helped  to  
determine  how  low  of  concentrations  the  HPLC  can  detect  after  using  SPE.  
The  manual  SPE  experimental  procedure  is  as  follows:  1  L  of  E-­‐pure  water  was  placed  in  each  of  three  3  
L  amber  bottles  and  then  ethanolamine,  acetic  acid,  and  formic  acid  were  weighed  out  so  that  each  jug  
contained  10  mM  of  the  respective  buffer.  The  pH  of  each  bottle  was  adjusted  to  pH  9,  pH  5,  and  pH  3,  
respectively,  with  ammonium  hydroxide  (14.8  M)  or  HCl  (6  M).  The  LOD  of  this  method  was  determined  
by   adding   the   paroxetine,   sertraline,   aripiprazole   (PSA)   solution   to   the   adjusted   buffer   solutions   in  
smaller  and  smaller  amounts.  These  solutions  were   then  extracted  under  vacuum  at  about  15  mmHg  
using  Oasis  HLB  6cc  SPE  columns  at  a  flow  rate  of  2  mL/min.  The  columns  were  prepped  with  5  mL  90%  
TBME/10%  MeOH  until   dried,      5  mL   100%  MeOH   until   dried,   and   5  mL   100%   E-­‐pure  H2O  until   there  
remained   a   thin   layer   of   water   on   the   column.   After   the   columns   were   loaded   with   the   PSA/buffer  
solutions,  a  centrifuge  tube  was  placed  underneath  the  columns  and  3-­‐5  mL  of  90%TBME/10%  MeOH  
was  used  to  extract  the  antidepressants  from  the  column.  The  centrifuge  tubes,  now  containing  3-­‐5  mL  
of  90%  TBME/10%  MeOH  and  the  antidepressant  compounds  that  eluted,  were  then  placed  in  a  sand  
bath  heated  to  about  45°  C  and  put  under  a  constant  flow  of  nitrogen  for  about  3  hours  to  evaporate  to  
dryness.   Then   0.5  mL   HPLC-­‐grade   methanol   was   added   to   each   tube,   which   was   vortexed   until   the  
compounds  dissolved.  Next,  0.25  mL  of  each  solution  was  placed  into  a  small  300  ʅ>   insert  which  was  
inside  a  regular  sized  amber  vial.  HPLC  was  run  on  each  of  the  vials  with  the  same  conditions  (70/30,  0.5  




   Automated  SPE/HPLC  
An  automated  SPE  was  tested  to  compare  to  the  manual  SPE  method.  Using  an  Oasis  HLB  3.9x20  mm,  15  
ʅŵ͕18  guard  column  as  the  SPE  pre-­‐concentration  medium,  a  similar  procedure  was  attempted.  The  
automation  was  accomplished  through  a  computer  program  that  communicated  with  a  pressurized  flow  
rate   adjustor   and   solution   valve   selectors,   which   were   hooked   up   to   HPLC-­‐grade   TBME,   HPLC-­‐grade  
methanol,   E-­‐pure   H2O   and   the   PSA/buffer   solution.   Two   filter   columns   were   placed   in   between   the  
sample  and  the  guard  column  in  the  HPLC  set-­‐up  in  order  to  increase  the  longevity  of  the  guard  column  
and  the  analytical  column.  The  pre-­‐concentration  column,  as  in  the  Oasis  HLB  guard  column  mentioned  
earlier,  was  prepped  by  pumping  90%  TBME/10%  MeOH  for  1  min  at  10  mL/min,  then  100%  MeOH  for  1  
min  at  10  mL/min,  and  finally  100%  E-­‐pure  H2O  for  2  min  at  10  mL/min.  The  1  L  PSA/buffer  solution  was  
then  pumped  through  the  column  for  100  min  at  10  mL/min.  When  this  time  lapsed,  the  HPLC  method  
was   initiated.   The   first   attempt   to   separate   the   peaks   included  pumping  100%  MeOH   for  30   seconds  
immediately  followed  by  70%  MeOH/30%  pH  9  ethanolamine  buffer  for  30  minutes  total.  The  method  
that  gave  consistent  peaks  for  all  three  compounds  was  70%  MeOH/30%  pH  9  buffer  for  the  entire  run,  
which  was  set  to  about  50  mins.  
After   the   automated   SPE   process   was   used   to   determine   the   LOD   with   the   PSA/buffer   solution,  
wastewater  was   tested.   This  water,   after   being   passed   through   a   primary   and   secondary  wastewater  
treatment   to   remove  most   of   the   organic   and   inorganic  materials,   then   a   sand   filtration   and   finally,  
through  a  UV  system  to  kill  off  any   remaining  bacteria,  was  obtained   from  the  St.   JohŶ͛ƐtĂƐƚĞǁĂƚĞƌ
Treatment  Plant.  
Part  2:  Analysis  of  wastewater  
Preparation  of  wastewater  
Each  liter  of  wastewater  collected  was  filtered  through  a  0.8  ʅm  nylon  filter  followed  by  a  0.45  
ʅm   nylon   filter.   The   pH   of   the   water   was   then   changed   to   pH   9   by   adding   ethanolamine   to   a  
concentration  of  10  mM  and  adjusting  to  pH  9  using  6  M  HCl.  This  pH  9  water/buffer  solution  was  then  
filtered   through   another   0.45   ʅm   nylon   filter   in   order   to   prevent   large   particles   from   entering   and  
obstructing  the  HPLC  columns.  These  solutions  were  then  run  through  the  automated  SPE/HPLC/MS  as  
described  in  the  following  paragraphs.  
A   solution   of   3700   ppm   (about   10   mM)   paroxetine   (active   ingredient   in   the   antidepressant   Paxil)  
dissolved   in   MeOH   was   made.   This   paroxetine   solution   was   pipetted   into   the   1   L   sample   of   pH   9  
wastewater  to  be  at  a  concentration  of  0.74  ppm.  
   Automated  SPE/HPLC  
The   1   L   paroxetine/wastewater   sample   was   pumped   through   a   15   ʅm   Oasis   HLB   online   pre-­‐
concentration   column   at   10  mL/min.  When   100  minutes   passed,   the   HPLC  method  was   enacted:   30  
seconds  of  100%  MeOH  and  then  70%  MeOH/30%  pH  9  ethanolamine  buffer  for  40  mins.  This  last  step  
was   changed   to   a   45%/55%   method   after   a   few   runs   to   increase   separation   between   the   peaks.  
Between  runs,  the  SPE  column  was  automatically  equilibrated  by  pumping  20  mL  of  100%  MeOH  and  20  
mL   of   E-­‐pure   H2O.   This   SPE/HPLC   method   was   followed   as   described   above   first   with   the  
paroxetine/wastewater   sample,   and   the   paroxetine   peak   was   apparent   in   the   chromatogram.   The  
concentration  of  paroxetine  after  this  SPE/HPLC  method  was  comparable  to  the  concentration  following  
the   E-­‐pure   PSA   solution   method   based   on   the   height   and   width   of   the   peaks   in   each   HPLC  
chromatogram.   After   discovering   peaks   in   the   chromatogram   that   did   not   pertain   to   paroxetine,   the  
wastewater   was   evaluated   with   HPLC-­‐MS   without   the   addition   of   the   antidepressant   in   order   to  
determine  what  compounds  pertained  to  these  peaks.  
Separation  was  accomplished  using  the  following  conditions:  
   2.6  ʅŵϭϴ<ŝŶĞƚĞǆĐŽůƵŵŶ  
   Mobile  phase  of  45%  MeOH/55%  100  mM  pH  9  ethanolamine  buffer  
   40  mins  run  time  at  0.500  mL/min  
   Thermoscientific  Surveyor  HPLC  
 Advantage  MS  using  an  ESI  source  
Three   distinct   peaks   consistently   showed   on   the   chromatograph.   To   identify   which   compounds  
pertained  to  each  peak,  fractions  were  collected  during  multiple  HPLC  runs.  The  three  consistent  peaks  
in  the  wastewater  samples  were  analyzed  three  different  ways  in  order  to  identify  them:  
1.  MS  
 An  ESI  probe  source  was  used  and  a  mass  range  of  50-­‐1000  m/z  was  set.  
2.  NMR  
 The  collective  fractions  were  vacuum  dried  under  nitrogen,  dissolved  in  deuterated  chloroform  
and  run  through  a  1H-­‐NMR  at  a  1024  scan  rate  and  13C-­‐NMR.  
3.  GC/MS  
 1  ʅL  of  sample  was  injected  and  run  at  300°C  for  30  minutes  with  a  split  ratio  of  10:1.  
  
RESULTS   
Part  1:  Determining  the  LOD  
The   following   table   comprises   the   HPLC/MS   data   that   was   used   to   distinguish   which   peak  
belongs  to  which  antidepressant  compound.  
Table  1:  HPLC/MS  data  from  all  six  antidepressants  with  a  70%  MeOH/30%  pH  9  buffer  solution,  0.500  mL  flow  rate,  215  nm  
  
  
Compound   Brand  Name   Molec.  Weight  (g/mol)   LC  -­‐  retention  time  (min)   MS  -­‐  m/z  
Escitalopram  
oxalate   Lexapro   414.43   5.97   325.15  
Quetiapine  
fumerate   Seroquel   383.1   6.70   384.14  
Paroxetine   Paxil   365.82   7.38   330.16  
Ziprasidone   Geodon   467.4   11.89   413.17  
Sertraline   Zoloft   342.69   19.08   305.94  
Aripiprazole   Abilify   448.39   35.60   448.76  
The  following  are  results  from  each  distinct  method:  
Direct  Injection  
 A  mobile  phase  of  70%  MeOH/30%  pH  9  ethanolamine  buffer  created  the  greatest  amount  of  
separation  and  detection.  
 A  solution  of  about  13  ppm  was  the  lowest  detectable  concentration  of  direct  injection  with  the  
HPLC.  This  is  the  starting  concentration  of  the  manual  SPE  method.  
Manual  SPE  
 The   pH   5   solution   gave   the   most   quantifiable   results   with   both   the   manual   SPE   and   the  
automated  SPE  method.  
 A  0.014  ppm  solution  was  the   lowest  detectable  concentration  under  the  manual  SPE  method  
with  the  HPLC.  
 Most  of  the  compounds  tended  to  elute  off  the  column  later  when  at  lower  concentrations.  
Automated  SPE  
 A   0.0072   ppm   solution   was   the   lowest   detectable   concentration   under   the   automated   SPE  
method  with  HPLC.  
 A  0.36  ppm  solution  was  the  lowest  detectable  concentration  under  the  automated  SPE  method  
with  the  APCI  MS  so  far.  Future  work  will  be  done  to  determine  if  it  can  detect  any  lower.  
 An  APCI  source  has  a  lower  detection  limit  than  an  ESI  source  for  these  compounds.  
Part  2:  Analysis  of  wastewater  
 The  pH  9  solution  of  wastewater  showed  three  distinct  peaks.  
 These   compounds   eluted   consistently   around   6.75,   8.10,   and   9.25  minutes   under   the   stated  
conditions.  
 These  compounds  were  in  a  significant  concentration  in  the  tenths  of  ppm  range.  
 No  peaks  were  apparent  when  a  GC/MS  method  was  enacted.  
 A  1H-­‐NMR  of  each  fraction  did  not  show  any  significant  peaks.  
  
  
Elution  time  (min)   Mass  range  (m/z)  
6.75   281-­‐282  &  477-­‐478  
8.10   259-­‐260  
9.25   513-­‐515  
  
DISCUSSION  
Part  1:  Determination  of  LOD  
Figures   1-­‐12   support   the   results   displayed   in   Table   1.   They   include   chromatograms   of   each  
antidepressant;   all   six   antidepressants   combined;   a   combination   of   the   three   antidepressants  
paroxetine,  sertraline  and  aripiprazole  at  a  high  concentration  as  well  as  at  the  LOD.  An  explanation  is  
included  with  each  figure.  
  
Table  2:  Mass  range  based  on  elution  time  of  the  compound  
  
                  
  
  
                  
  
  
                    
  
  
Figure  1:  Chromatograms  of  paroxetine  over  a  20  minute  elution  (a)  HPLC  (b)  MS  (c)  MS  with  mass  range  of  330-­‐331  m/z  
Figure  2:  Chromatograms  of  sertraline  over  a  30  minute  elution  (a)  HPLC  (b)  MS  (c)  MS  with  mass  range  of  305-­‐306  m/z  



















                    
  
  
                    
  
  




Figures  1-­‐6  show  the  separate  times  the  six  antidepressants  eluted  from  the  column  and  were  
detected   by   the   HPLC,   as  well   as   their  MS   chromatograms.   The   peaks   from   the  MS   chromatograms  
become  more  defined  when  selected  ion  monitoring  is  used.  The  mass  range  is  narrowed  down  to  the  
smallest  range  containing  the  most  common  ion  of  the  antidepressant.  
  
Figure   7   shows   the   ability   of   the   70%  MeOH/30%   pH   9   buffer   mobile   phase   to   successfully  
separate  the  six  antidepressant  peaks  when  the  antidepressants  from  Figures  1-­‐6  are  added  together.  
Figure  4:  Chromatograms  of  escitalopram  oxalate  over  a  20  minute  elution  (a)  HPLC  (b)  MS  (c)  MS  with  mass  range  of  325-­‐326  m/z  
Figure  5:  Chromatograms  of  ziprasidone  over  a  30  minute  elution  (a)  HPLC  (b)  MS  (c)  MS  with  mass  range  of  413-­‐414  m/z  


















           
  
  
Figure   8   was   taken   at   both   the   highest   concentration   tested   and   the   lowest   concentration  
detectable  with  direct   injection.   The   latter  was  obtained  by   injecting   lower  and   lower   concentrations  
until  the  peaks  were  no  longer  visible.  Figure  8(b)  therefore  shows  the  concentration  at  which  the  LOD  
was  reached  under  direct  injection.  
  




Figure   9   shows   the   highest   concentration   tested   for   manual   SPE,   which   was   the   same  
concentration  as  the  lowest  detectable  by  direct  injection  as  well  as  the  lowest  concentration  detectable  
after  manual  SPE,  which  was  determined  to  be  0.014  ppm  at  pH  9.  
Figure  7:  Chromatograms  of  six  antidepressants  at  ~333  ppm  using  direct  injection  and  a  40  min  elution  (a)  HPLC  (b)  MS  
Figure  8:  HPLC  chromatograms  of  paroxetine,  sertraline  and  aripiprazole  using  direct  injection  and  a  40  minute  elution  













Figure  10  shows  0.036  ppm  pH  9  PSA  solution  chromatograms  after  automated  SPE.  The  MS  
chromatogram  was  taken  using  ESI.  No  peaks  were  visible  with  ESI  at  this  concentration.  
  




Figure   11   represents   a   0.36   ppm   pH   9   PSA   solution   after   automated   SPE   with   a   MS  
chromatogram   using   Atmospheric   Pressure   Chemical   Ionization   (APCI)   instead   of   ESI,   and   the   peaks  
shown  indicate  that  APCI  source  was  able  to  detect  all  three  compounds  at  this  concentration.  
Figure  9:  HPLC  chromatograms  of  paroxetine,  sertraline  and  aripiprazole  after  manual  SPE  and  a  40  minute  elution  
(a)  at  13  ppm  (b)  at  0.014  ppm  
Figure  10:  Chromatograms  of  paroxetine,  sertraline  and  aripiprazole  at  0.036  ppm  after  automated  SPE  and  a  60  minute  









             
  
  
Figure  12  displays  a  0.0072  ppm  pH  9  PSA  solution  after  automated  SPE.  This  is  the  lowest  
concentration  detectable  by  the  HPLC  after  automated  SPE.  MS  was  employed  because,  as  seen  in  figure  
10(b),  it  was  no  longer  useful  at  this  concentration  level.  
  
  
Figure  11:  Chromatograms  of  paroxetine,  sertraline  and  aripiprazole  at  0.36  ppm  after  automated  SPE  and  a  60  minute  
elution  (a)  HPLC  (b)  MS-­‐APCI  with  mass  ranges  330-­‐331  m/z,  305-­‐307  m/z  and  448-­‐449  m/z.  
Figure  12:  HPLC  chromatogram  of  paroxetine,  sertraline  and  aripiprazole  at  0.0072  ppm  after  automated  SPE  





  Part  2:  Analysis  of  wastewater  
Figure  13  and  14  are  from  the  analysis  of  wastewater  using  SPE/HPLC-­‐MS.  While  many  similar  
chromatograms  were  compiled,  these  showed  the  data  the  most  clearly.  Figure  15  displays  the  1H-­‐NMR  
of  the  third  peak  fraction  collection  as  described  in  the  methods  section.  





Figure  13:  HPLC  chromatograms  of  30  minute  elutions  after  automated  SPE  and  a  30  minute  elution  (a)  wastewater  
plus  0.74  ppm  paroxetine  (b)  wastewater  with  three  main  unknown  peaks  at  5.80,  7.12  and  9.30  minutes.  
Figure  14:  LC  Chromatogram  of  1  L  of  wastewater  and  Mass  
Spectra  with  mass  ranges  281-­‐282,  477-­‐478,  259-­‐260  and  
513-­‐515  m/z.  
Figure  15:  1H-­‐NMR  of  the  3rd  peak  collected  fraction.  
Water  and  deuterated  chloroform  are  present  at  1.5  





Figure   13(a)   clearly   shows   there   are   some   compounds   in   the   wastewater   which   have  
concentrations  that  are  not  as  great  as  0.74  ppm  like  the  paroxetine  which  was  added,  but  greater  than  
the  0.0072  ppm  LOD  of  the  automated  method  as  discovered  in  Part  1.  This  can  be  concluded  because  
the  average  absorbance  of  the  LOD  chromatogram  was  about  1500  and  the  average  absorbance  of  the  
three  peaks  in  the  wastewater  chromatogram  was  about  60,000,  therefore  much  higher  than  the  LOD.  
In   Figure  13(b),   three  distinct   peaks   can  be   seen  which,   after   the  procedure  was   replicated  20   times,  
were  averaged  to  appear  at  6.75,  8.10  and  9.25  minutes  as  shown  in  Table  2.  
Figure  14  seemed  to  give  an  insight  into  what  the  compounds  might  be  because  of  the  mass  range  data  
that  was   recorded.  The  6.25  minute  peak  pertained   to  mass   ranges  of  281-­‐282  and  477-­‐478  m/z,   the  
8.10  peak  pertained  to  a  mass  range  of  259-­‐260  m/z  and  the  9.25  peak  pertained  to  a  mass  range  of  
513-­‐515  m/z.  After  doing  some   research  on  the   internet,  no  common  pharmaceuticals  or  compounds  
commonly  found  in  wastewater  were  matched  to  this  data.  The  fact  that  these  compounds  were  able  to  
be   detected   by   the   MS   detector   leads   to   the   following   conclusion:   because   the   LOD   of   the   LC-­‐MS  
method   in   Part   1   was   0.14   ppm,   the   range   of   the   concentrations   of   these   three   analytes   can   be  
approximated  to  be  between  0.36  ppm  and  0.74  ppm.  This  range  is  only  speculation  based  on  previous  
work,  without  knowledge  of  the  actual  compound  and  its  ionization  characteristics  in  the  MS.  
The  1H-­‐NMR  of  the  third  peak  fraction  as  shown  in  Figure  15  was  very  similar  to  the  1H-­‐NMR  of  the  first  
and  second  peaks  in  the  chromatogram,  and  therefore  was  not  useful  in  the  identification  in  any  of  the  
compounds.  Furthermore,  the  spectra  were  not  matched  to  any  known  compound.  
GC/MS   chromatography   was   not   useful   in   the   identification   of   any   of   the   peaks   either,   therefore   a  
chromatogram  is  not  included.  
Based  on  the  previous  methods  of  analysis,  this  data  is  inconclusive  in  determining  the  identity  of  these  
analytes.  In  conclusion,  the  concentrations  of  the  three  unknown  analytes  in  the  wastewater  were  not  
significant  enough  to  determine  their  composition  with  1H-­‐NMR,  GC-­‐MS  or  LC-­‐MS.  
That   being   said,   there   are   still   compounds   in   a   concentration   significant   enough   to   appear   on   the  
SPE/HPLC-­‐MS   method,   therefore   most   likely   above   a   concentration   of   the   LOD,   0.0072   ppm.   This  
concentration   is  of   concern   to   the  aquatic  environment   in   Lake  Gemini,   into  which   the  wastewater   is  
discharged.  Further  work  must  be  done  by  improving  this  method  or  using  other  methods  of  analysis  to  
identify  the  compounds  seen  on  the  chromatograms.  
   Conclusion  
The  automated  SPE  method   improved  the  LOD  of   the  regular  HPLC  method  by  1800  times.  Using  this  
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FUTURE  RESEARCH  
A   continuation   of   this   research   would   include   identifying   the   three   compounds   found   in  
significant  concentration  by  collecting  additional  fractions  and  analyzing  them  with  MS,  NMR,  and  other  
methods.  Once  the  compounds  are  identified,  a  further  quantitative  analysis  would  be  performed.  Pure  
samples  would  be  tested  in  E-­‐pure  water  in  order  to  determine  the  initial  concentration  of  each  of  these  
chemicals   in   the  wastewater.   These   concentrations  would   be   compared   to   known   toxicity   levels   and  
determined  to  be  toxic  or  non-­‐toxic.  
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